Skip Main Navigation
Office of Management and Budget
President's Budget
Management
Information &
Regulatory Affairs
Legislative Information
Agency Information

Public Comment Regarding: FDA Policy on Use of Ozone-Depleting Substances in Medical Products

Date: 6/17/2002

Signer Organization
David D. Doniger - Senior Attorney and Policy Director - NRDC Climate Center